These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29248179)

  • 21. Oncologic outcomes after robot-assisted versus laparoscopic distal pancreatectomy: Analysis of the National Cancer Database.
    Raoof M; Nota CLMA; Melstrom LG; Warner SG; Woo Y; Singh G; Fong Y
    J Surg Oncol; 2018 Sep; 118(4):651-656. PubMed ID: 30114321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection.
    Ellis RJ; Ho JW; Schlick CJR; Merkow RP; Bentrem DJ; Bilimoria KY; Yang AD
    Ann Surg Oncol; 2020 Mar; 27(3):909-918. PubMed ID: 31691112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?
    Ranney DN; Mulvihill MS; Yerokun BA; Fitch Z; Sun Z; Yang CF; D'Amico TA; Hartwig MG
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):543-551. PubMed ID: 28498967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National failure to operate on early stage pancreatic cancer.
    Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS
    Ann Surg; 2007 Aug; 246(2):173-80. PubMed ID: 17667493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma.
    Salami A; Alvarez NH; Joshi ART
    HPB (Oxford); 2017 Nov; 19(11):1008-1015. PubMed ID: 28838634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer.
    Bergquist JR; Ivanics T; Shubert CR; Habermann EB; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB; Truty MJ
    Ann Surg Oncol; 2017 Jun; 24(6):1731-1738. PubMed ID: 28070725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
    Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
    J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
    Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
    Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?
    Kulshrestha S; Sweigert PJ; Tonelli C; Bunn C; Luchette FA; Abdelsattar ZM; Pawlik TM; Baker MS
    J Surg Oncol; 2022 Mar; 125(3):414-424. PubMed ID: 34617590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma.
    Raman V; Jawitz OK; Voigt SL; Yang CJ; Wang H; Harpole DH; D'Amico TA
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1626-1635.e1. PubMed ID: 31740115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resectable Distal Pancreas Cancer: Time to Reconsider the Role of Upfront Surgery.
    Nelson DW; Chang SC; Grunkemeier G; Dehal AN; Lee DY; Fischer TD; DiFronzo LA; O'Connor VV
    Ann Surg Oncol; 2018 Dec; 25(13):4012-4019. PubMed ID: 30229418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative mortality for pancreatectomy: a national perspective.
    McPhee JT; Hill JS; Whalen GF; Zayaruzny M; Litwin DE; Sullivan ME; Anderson FA; Tseng JF
    Ann Surg; 2007 Aug; 246(2):246-53. PubMed ID: 17667503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
    Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
    Czosnyka NM; Borgert AJ; Smith TJ
    HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.
    van der Geest LGM; Lemmens VEPP; de Hingh IHJT; van Laarhoven CJHM; Bollen TL; Nio CY; van Eijck CHJ; Busch ORC; Besselink MG;
    Br J Surg; 2017 Oct; 104(11):1568-1577. PubMed ID: 28832964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.